IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q4 2021 Holdings

Filed 2022-02-14 | 5 holdings | $238.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$153.1K1,111,11164.1%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$43.0K3,846,15418.0%
Epizyme Inc(EPZMEUR)COM29428V104$22.9K9,166,6679.6%
Viracta Therapeutics IncCOM92765F108$13.5K3,7005.7%
Epizyme IncCallCOM29428V904$6.4K2,546,1342.7%